New focus on pharmacist-led vaccination efforts to curb childhood ENT infections and HPV-related cancers

A recent study highlights the vital role of routine childhood vaccines, particularly pneumococcal conjugate and HPV vaccines, in preventing ear, nose, throat infections and HPV-related cancers, with pharmacists poised to boost immunisation coverage amid misinformation challenges.

A study published in the journal Children argues that routine childhood vaccination remains central to preventing infections in the ear, nose and throat, with pneumococcal conjugate vaccines doing much of the heavy lifting against acute otitis media and HPV vaccination offering protection that reaches into adulthood. The authors frame both vaccines as part of the same preventive strategy: one cuts the burden of common childhood ENT disease, while the other helps avert HPV-related infections that can later contribute to cancer.

The evidence for pneumococcal vaccination is especially strong in paediatric ear disease. Research cited in the article shows that the move from earlier formulations to newer, higher-valency vaccines has been linked with fewer complicated ear infections, fewer surgical procedures and lower rates of otitis media-related care. Other studies support that picture, including work showing reduced pneumococcal carriage in young children and marked falls in outpatient visits for otitis media after PCV13 was introduced. Even so, the microbiology has shifted rather than disappeared, with non-vaccine pneumococcal serotypes and bacteria such as Haemophilus influenzae and Moraxella catarrhalis taking on a larger role.

HPV vaccination, meanwhile, is presented as a first step against infections that can lead to oropharyngeal cancers and other disease later in life. The American Academy of Pediatrics recommends the vaccine from age nine for boys and girls, and its guidance reflects the broader evidence that HPV immunisation prevents the vast majority of cancers caused by the virus. The study also notes that HPV vaccination should be given before exposure, since it blocks new infection rather than treating established disease.

The article places pharmacists at the centre of efforts to improve uptake of both vaccines, particularly because misinformation still deters some families. Concerns about infertility and claims that vaccination encourages adolescent sexual activity remain common talking points, despite evidence to the contrary. The Pediatric Pharmacy Association has argued for wider pharmacist authority to vaccinate children as young as three, while also urging stronger training in paediatric immunisation, better use of state vaccine records and participation in the Vaccines for Children programme to improve access for uninsured and Medicaid patients.